This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Clinton, NJ (US) (2019)
- Niantic, CT (US) (2022)
Company Filing History:
Years Active: 2019-2022
Title: Nathan R. Domagalski: Innovator in Hepatitis C Treatment
Introduction
Nathan R. Domagalski is a notable inventor based in Niantic, Connecticut, recognized for his significant contributions to the pharmaceutical industry. He holds two patents, showcasing his expertise and innovative spirit in developing therapeutic solutions, especially for Hepatitis C.
Latest Patents
Among his latest patents, Domagalski has developed a complex process for the preparation of N-((1R,2S,5R)-5-(-butylamino)-2-((S)-3-(7-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide. This invention focuses on enhancing the synthesis processes related to specific compounds used in medical applications. Additionally, he has contributed to the field by working on Hepatitis C virus inhibitors, specifically methods for making asunaprevir, which serves as an effective treatment for Hepatitis C virus (HCV) infections along with its various intermediates.
Career Highlights
Nathan R. Domagalski is affiliated with Bristol-Myers Squibb Company, a prestigious pharmaceutical corporation known for its commitment to research and development in life-saving medications. His work within this organization emphasizes his role in advancing healthcare and improving patient outcomes through innovative drug therapies.
Collaborations
Throughout his career, Domagalski has collaborated with several notable professionals, including Scott A. Savage and Burcu Selin Aytar. These partnerships reflect his dedication to teamwork and knowledge sharing in the pursuit of groundbreaking pharmaceutical advancements.
Conclusion
In summary, Nathan R. Domagalski's inventive contributions to Hepatitis C treatment and the pharmaceutical industry highlight his status as a significant figure in modern medicine. With his patents and collaborative efforts, he continues to pave the way for advancements that can change lives and improve health outcomes worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile